Just reading the annual report and here is one relevant quote:
"Discussions with prospective partners span ArTiMist™, the other
clinical-stage oral sprays, as well as the application of SUDA’s
OroMist drug delivery technology to new drugs. Discussions are
at various stages with some companies having completed due
diligence and initiated deal negotiations."
AGM Date & Time, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $155.1M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $19.97K | 133.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 233106 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 218231 | 6 |
View Market Depth
| Last trade - 10.52am 08/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |